New research identifies the specific molecular pathway BPC-157 uses to promote blood vessel formation – it works by stabilizing BACH1 protein through FBXO22 regulation. This breakthrough helps explain BPC-157’s proven regenerative effects across multiple organ systems and addresses the key scientific gap that has limited its clinical adoption. The research validates BPC-157’s angiogenic properties with concrete mechanistic evidence, strengthening the scientific foundation for practitioner use.
For your business
We now have the molecular mechanism showing exactly how BPC-157 drives new blood vessel formation, filling a critical knowledge gap that strengthens clinical confidence in the compound.